These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 9793852

  • 1. Definitive cure of recurrent prosthetic endocarditis using silver-coated St. Jude Medical heart valves: a preliminary case report.
    Carrel T, Nguyen T, Kipfer B, Althaus U.
    J Heart Valve Dis; 1998 Sep; 7(5):531-3. PubMed ID: 9793852
    [Abstract] [Full Text] [Related]

  • 2. Preliminary experience with Silzone-coated St. Jude medical valves in acute infective endocarditis.
    Bertrand S, Houel R, Vermes E, Soustelle C, Hillion ML, Loisance D.
    J Heart Valve Dis; 2000 Jan; 9(1):131-4. PubMed ID: 10678385
    [Abstract] [Full Text] [Related]

  • 3. First clinical experience with a mechanical valve with silver coating.
    Brutel de la Riviere A, Dossche KM, Birnbaum DE, Hacker R.
    J Heart Valve Dis; 2000 Jan; 9(1):123-9; discussion 129-30. PubMed ID: 10678384
    [Abstract] [Full Text] [Related]

  • 4. Prosthetic heart valves with silver-coated sewing cuff fabric: early morphological features in two patients.
    Butany J, Scully HE, VanArsdell G, Leask R.
    Can J Cardiol; 2002 Jul; 18(7):733-8. PubMed ID: 12167960
    [Abstract] [Full Text] [Related]

  • 5. Seven-year results with the St Jude Medical Silzone mechanical prosthesis.
    Jamieson WR, Fradet GJ, Abel JG, Janusz MT, Lichtenstein SV, MacNab JS, Stanford EA, Chan F.
    J Thorac Cardiovasc Surg; 2009 May; 137(5):1109-15.e2. PubMed ID: 19379975
    [Abstract] [Full Text] [Related]

  • 6. In vivo efficacy of silver-coated (Silzone) infection-resistant polyester fabric against a biofilm-producing bacteria, Staphylococcus epidermidis.
    Illingworth BL, Tweden K, Schroeder RF, Cameron JD.
    J Heart Valve Dis; 1998 Sep; 7(5):524-30. PubMed ID: 9793851
    [Abstract] [Full Text] [Related]

  • 7. Early outcome after surgery for active native and prosthetic aortic valve endocarditis.
    Gabbieri D, Dohmen PM, Linneweber J, Grubitzsch H, von Heymann C, Neumann K, Halle E, Konertz WF.
    J Heart Valve Dis; 2008 Sep; 17(5):508-24; discussion 525. PubMed ID: 18980085
    [Abstract] [Full Text] [Related]

  • 8. Pathologic analysis of 19 heart valves with silver-coated sewing rings.
    Butany J, Leask RL, Desai ND, Jegatheeswaran A, Silversides C, Scully HE, Feindel C.
    J Card Surg; 2006 Sep; 21(6):530-8. PubMed ID: 17073948
    [Abstract] [Full Text] [Related]

  • 9. [Prosthetic valve endocarditis: about 14 cases].
    Ben Omrane S, Kaouel K, Ben Ali W, Ben Mrad M, Ziadi J, Anis Rjeb M, Denguir R, Kalfat T, Khayati A.
    Tunis Med; 2008 Nov; 86(11):978-82. PubMed ID: 19213488
    [Abstract] [Full Text] [Related]

  • 10. Native versus primary prosthetic valve endocarditis: comparison of clinical features and long-term outcome in 353 patients.
    Romano G, Carozza A, Della Corte A, De Santo LS, Amarelli C, Torella M, De Feo M, Cerasuolo F, Cotrufo M.
    J Heart Valve Dis; 2004 Mar; 13(2):200-8; discussion 208-9. PubMed ID: 15086258
    [Abstract] [Full Text] [Related]

  • 11. Surgical treatment of infective mitral valve endocarditis: predictors of early and late outcome.
    Alexiou C, Langley SM, Stafford H, Haw MP, Livesey SA, Monro JL.
    J Heart Valve Dis; 2000 May; 9(3):327-34. PubMed ID: 10888086
    [Abstract] [Full Text] [Related]

  • 12. [Surgical correction with homograft in native or prosthetic aortic valve infective endocarditis].
    Gamba A, Terzi A, Ferrazzi P, Farina C, Suter F.
    Ital Heart J Suppl; 2002 Jul; 3(7):728-37. PubMed ID: 12187633
    [Abstract] [Full Text] [Related]

  • 13. The St. Jude "Silzone" valve: midterm results in treatment of active endocarditis.
    Seipelt RG, Vazquez-Jimenez JF, Seipelt IM, Franke A, Chalabi K, Schoendube FA, Messmer BJ.
    Ann Thorac Surg; 2001 Sep; 72(3):758-62; discussion 762-3. PubMed ID: 11565654
    [Abstract] [Full Text] [Related]

  • 14. Recurrent endocarditis in silver-coated heart valve prosthesis.
    Kjaergard HK, Tingleff J, Abildgaard U, Pettersson G.
    J Heart Valve Dis; 1999 Mar; 8(2):140-2. PubMed ID: 10224571
    [Abstract] [Full Text] [Related]

  • 15. Biocompatibility of silver-modified polyester for antimicrobial protection of prosthetic valves.
    Tweden KS, Cameron JD, Razzouk AJ, Holmberg WR, Kelly SJ.
    J Heart Valve Dis; 1997 Sep; 6(5):553-61. PubMed ID: 9330181
    [Abstract] [Full Text] [Related]

  • 16. Surgical treatments for infective endocarditis involving valve annulus.
    Ishikawa S, Kawasaki A, Neya K, Abe K, Suzuki H, Koizumi S, Shibuya H, Horikawa M, Ueda K.
    Ann Thorac Cardiovasc Surg; 2009 Dec; 15(6):378-81. PubMed ID: 20081746
    [Abstract] [Full Text] [Related]

  • 17. Time-related risk of the St. Jude Silzone heart valve.
    Grunkemeier GL, Jin R, Im K, Holubkov R, Kennard ED, Schaff HV.
    Eur J Cardiothorac Surg; 2006 Jul; 30(1):20-7. PubMed ID: 16730188
    [Abstract] [Full Text] [Related]

  • 18. [Employment of St. Jude "silzone" valve in the surgical treatment of early prosthetic valve endocarditis: a preliminary case report and review of the literature].
    García Fuster R, Montero Argudo JA, Gil Albarova O, Hornero Sos F, Cánovas S, Dalmau Sorlí MJ.
    Rev Esp Cardiol; 2000 Jan; 53(1):139-41. PubMed ID: 10701333
    [Abstract] [Full Text] [Related]

  • 19. [Surgery in acute bacterial endocarditis. Restraints--possibilities].
    Dreyfus G.
    Arch Mal Coeur Vaiss; 1993 Dec; 86(12 Suppl):1869-75. PubMed ID: 8024393
    [Abstract] [Full Text] [Related]

  • 20. Importance of implant technique on risk of major paravalvular leak (PVL) after St. Jude mechanical heart valve replacement: a report from the Artificial Valve Endocarditis Reduction Trial (AVERT).
    Englberger L, Schaff HV, Jamieson WR, Kennard ED, Im KA, Holubkov R, Carrel TP, AVERT Investigators.
    Eur J Cardiothorac Surg; 2005 Dec; 28(6):838-43. PubMed ID: 16275007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.